TrialThe Lancet. Oncology2017

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.

Heather A Wakelee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.